Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 7
2004 8
2005 8
2006 7
2007 5
2008 4
2009 5
2010 6
2011 5
2012 4
2013 5
2014 5
2015 3
2016 3
2017 5
2018 4
2019 2
2020 1
2021 7
2022 10
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
State-of-the-Art Cancer Immunotherapies.
Nagase H, Kato T, Yoshimoto T. Nagase H, et al. Among authors: yoshimoto t. Int J Mol Sci. 2024 Feb 22;25(5):2532. doi: 10.3390/ijms25052532. Int J Mol Sci. 2024. PMID: 38473780 Free PMC article.
Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.
Chiba Y, Mizoguchi I, Hasegawa H, Ohashi M, Orii N, Nagai T, Sugahara M, Miyamoto Y, Xu M, Owaki T, Yoshimoto T. Chiba Y, et al. Among authors: yoshimoto t. Cell Mol Life Sci. 2018 Apr;75(8):1363-1376. doi: 10.1007/s00018-017-2724-5. Epub 2017 Dec 7. Cell Mol Life Sci. 2018. PMID: 29218601 Review.
Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation.
Sakamoto E, Katahira Y, Mizoguchi I, Watanabe A, Furusaka Y, Sekine A, Yamagishi M, Sonoda J, Miyakawa S, Inoue S, Hasegawa H, Yo K, Yamaji F, Toyoda A, Yoshimoto T. Sakamoto E, et al. Among authors: yoshimoto t. Biology (Basel). 2023 Jan 12;12(1):123. doi: 10.3390/biology12010123. Biology (Basel). 2023. PMID: 36671815 Free PMC article. Review.
A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions.
Watanabe A, Mizoguchi I, Hasegawa H, Katahira Y, Inoue S, Sakamoto E, Furusaka Y, Sekine A, Miyakawa S, Murakami F, Xu M, Yoneto T, Yoshimoto T. Watanabe A, et al. Among authors: yoshimoto t. Front Immunol. 2021 Sep 17;12:757669. doi: 10.3389/fimmu.2021.757669. eCollection 2021. Front Immunol. 2021. PMID: 34603342 Free PMC article. Review.
Antitumor activities of interleukin-27 on melanoma.
Nagai H, Oniki S, Fujiwara S, Xu M, Mizoguchi I, Yoshimoto T, Nishigori C. Nagai H, et al. Among authors: yoshimoto t. Endocr Metab Immune Disord Drug Targets. 2010 Mar;10(1):41-6. doi: 10.2174/187153010790827920. Endocr Metab Immune Disord Drug Targets. 2010. PMID: 19845503 Review.
Interleukins and cancer immunotherapy.
Yoshimoto T, Morishima N, Okumura M, Chiba Y, Xu M, Mizuguchi J. Yoshimoto T, et al. Immunotherapy. 2009 Sep;1(5):825-44. doi: 10.2217/imt.09.46. Immunotherapy. 2009. PMID: 20636026 Review.
A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant.
Sonoda J, Mizoguchi I, Inoue S, Watanabe A, Sekine A, Yamagishi M, Miyakawa S, Yamaguchi N, Horio E, Katahira Y, Hasegawa H, Hasegawa T, Yamashita K, Yoshimoto T. Sonoda J, et al. Among authors: yoshimoto t. Int J Mol Sci. 2023 May 22;24(10):9094. doi: 10.3390/ijms24109094. Int J Mol Sci. 2023. PMID: 37240448 Free PMC article. Review.
104 results